Please wait while we load the requested 10-Q report or click the link below:
USANA Health Sciences Reports Results for Third Quarter 2018; Updates 2018 Outlook; Board Increases Share Repurchase Authorization
- Third quarter net sales of $296.8 million, an increase of 13.4% year-over-year
- Third quarter diluted earnings per share increased 27.8% year-over-year to $1.24
- Total Active Customers increased 9.2% year-over-year to 615,000
- Board increases share repurchase authorization
SALT LAKE CITY--(BUSINESS WIRE)--October 23, 2018--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal third quarter ended September 29, 2018.
For the third quarter of 2018, net sales were $296.8 million, compared with $261.8 million in the prior-year period, a 13.4% increase year-over-year. Unfavorable currency exchange rates negatively impacted net sales by $6.2 million for the quarter as compared to the prior year. The Company’s skin and personal care product category contributed approximately $9.5 million in incremental sales for the quarter. The Company’s total number of active Customers increased 9.2% year-over-year to 615,000.
The following information was filed by Usana Health Sciences Inc (USNA) on Tuesday, October 23, 2018 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one quarter to another to evaluate Usana Health Sciences Inc's financial trajectory
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were
removed , and by Usana Health Sciences Inc.